In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials. <a href="https://bit.ly/Lyman-COVID-19-podcast" target="_blank" rel="noopener">Find more on Medicine Matters oncology</a>

In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials. Find more on Medicine Matters oncology

In this Medicine Matters oncology podcast, we speak to Gary Lyman (Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, USA) about the impact of the COVID-19 outbreak on the conduct of cancer clinical trials. <a href="https://bit.ly/Lyman-COVID-19-podcast" rel="noopener noreferrer">Find more on Medicine Matters oncology</a>

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)

Interviews with clinical experts, discussing key issues in oncology.

Share Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)

Sign up to save your podcasts

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)

Conducting cancer clinical trials in the COVID-19 era (with Gary Lyman)